Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

By P. Pigny, É. Merlen, Y. Robert, C. Cortet-Rudelli, C. Decanter, S. Jonard, Didier Dewailly. Journal of Clinical Endocrinology and Metabolism, 2003

708 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/d00c4cc6bfcba08716908f75cda76e7c32e24831

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Marca
2. A. Volpe
3. D. Radi
4. E. Baraldi
5. A. C. Artenisio
6. Gaspare Stabile
7. C. Argento
8. G. Sighinolfi

Citations in the corpus

• Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (2010, background): “Accordingly circulating AMH levels in women with PCOS are two to three times higher than healthy controls (Fallat et al., 1997; Cook et al., 2002; Pigny et al., 2003; La Marca et al., 2004a, b; Laven et al., 2004; Mulders et al., 2004; Eldar-Geva et al., 2005; Piltonen et al., 2005; Wachs et al., 20”